A2 Bio’s Activator-Blocker CAR-T Cell Therapies Show Early Promise in Solid Cancers

Mainz Biomed N.V. announced that, together with its German partner laboratories, it will join a collective of physicians, healthcare professionals, laboratories and healthcare organizations in a national campaign to raise awareness for colorectal cancer screening.